William Blair Predicts Lower Earnings for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Equities research analysts at William Blair reduced their Q3 2025 earnings estimates for DENTSPLY SIRONA in a research note issued on Thursday, May 8th. William Blair analyst B. Vazquez now expects that the medical instruments supplier will earn $0.49 per share for the quarter, down from their previous estimate of $0.51. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. William Blair also issued estimates for DENTSPLY SIRONA’s Q3 2026 earnings at $0.53 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. During the same quarter in the prior year, the business earned $0.42 earnings per share. The business’s quarterly revenue was down 7.8% compared to the same quarter last year.

Several other research firms have also issued reports on XRAY. Wells Fargo & Company dropped their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Morgan Stanley lowered shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price objective for the company. in a research report on Tuesday, April 15th. Mizuho dropped their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, March 13th. Barrington Research raised their price target on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an “outperform” rating in a report on Monday. Finally, Piper Sandler lowered their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a report on Wednesday, April 30th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $20.36.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $16.60 on Monday. DENTSPLY SIRONA has a 52-week low of $12.16 and a 52-week high of $28.57. The firm has a fifty day moving average of $14.38 and a 200-day moving average of $17.48. The firm has a market capitalization of $3.31 billion, a P/E ratio of -8.02, a PEG ratio of 1.80 and a beta of 0.92. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 3.86%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is currently -14.10%.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier acquired 15,142 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Colonial Trust Co SC acquired a new position in DENTSPLY SIRONA during the 4th quarter worth $26,000. Riverview Trust Co bought a new position in shares of DENTSPLY SIRONA in the 4th quarter worth about $26,000. MassMutual Private Wealth & Trust FSB lifted its position in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after buying an additional 1,232 shares during the last quarter. UMB Bank n.a. grew its position in shares of DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after buying an additional 564 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new stake in DENTSPLY SIRONA during the first quarter worth about $25,000. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.